Welcome To Website IAS

Hot news
Achievement

Independence Award

- First Rank - Second Rank - Third Rank

Labour Award

- First Rank - Second Rank -Third Rank

National Award

 - Study on food stuff for animal(2005)

 - Study on rice breeding for export and domestic consumption(2005)

VIFOTEC Award

- Hybrid Maize by Single Cross V2002 (2003)

- Tomato Grafting to Manage Ralstonia Disease(2005)

- Cassava variety KM140(2010)

Centres
Website links
Vietnamese calendar
Library
Visitors summary
 Curently online :  12
 Total visitors :  4972276

USDA, FDA Sign MOU on Animal Biotechnology Regulation
Tuesday, 2021/01/26 | 08:24:59

January 20, 2021

The United States Department of Agriculture (USDA) and US Department of Health and Human Services signed the Memorandum of Understanding (MOU) finalizing the joint roles of the USDA and the Food and Drug Administration (FDA) in regulating products derived from animal biotechnology.

 

The MOU was signed on January 13, 2021, and complements USDA's issuance of an Advanced Notice Proposed Rulemaking (ANPR) on the Movement of Animals Modified or Developed by Genetic Engineering released three weeks prior. The MOU covers the responsibilities of the regulation of "amenable species" intended for agricultural purposes developed using genetic engineering. In it, USDA and FDA will both continue to implement existing laws and Acts when regulating the products. However, new roles are also highlighted such as USDA and FDA working together on a communication plan to explain FDA's role in overseeing animal genetic alterations using a streamlined, risk-based approach. USDA is also set to consult FDA when establishing a review process for the product derived by animal biotechnology.

 

The USDA explained in a press release that the MOU states that USDA will provide oversight of animals modified or developed through genetic engineering for human food from pre-market reviews to post-market food safety monitoring, while FDA will continue its review of intentional genomic alterations intended not just for agricultural use but for biopharma and non-heritable genetic alterations as well. The MOU intends for the transition of the FDA's pre-existing animal biotechnology regulatory responsibilities to USDA.

 

Read the MOU's details released by USDA to know more.

Back      Print      View: 35

[ Other News ]___________________________________________________
  • Beyond genes: Protein atlas scores nitrogen fixing duet
  • 2016 Borlaug CAST Communication Award Goes to Dr. Kevin Folta
  • FAO and NEPAD team up to boost rural youth employment in Benin, Cameroon, Malawi and Niger
  • Timely seed distributions in Ethiopia boost crop yields, strengthen communities’ resilience
  • Parliaments must work together in the final stretch against hunger
  • Empowering women farmers in the polder communities of Bangladesh
  • Depression: let’s talk
  • As APEC Concludes, CIP’s Food Security and Climate Smart Agriculture on Full Display
  • CIAT directly engages with the European Cocoa Industry
  • Breeding tool plays a key role in program planning
  • FAO: Transform Agriculture to Address Global Challenges
  • Uganda Holds Banana Research Training for African Scientists and Biotechnology Regulators
  • US Congress Ratifies Historic Global Food Security Treaty
  • Fruit Fly`s Genetic Code Revealed
  • Seminar at EU Parliament Tackles GM Crops Concerns
  • JICA and IRRI ignites a “seed revolution” for African and Asian farmers
  • OsABCG26 Vital in Anther Cuticle and Pollen Exine Formation in Rice
  • Akira Tanaka, IRRI’s first physiologist, passes away
  • WHO calls for immediate safe evacuation of the sick and wounded from conflict areas
  • Farmer Field School in Tonga continues to break new ground in the Pacific for training young farmers

 

Designed & Powered by WEBSO CO.,LTD